Literature DB >> 31554955

Generation of blood vessel organoids from human pluripotent stem cells.

Reiner A Wimmer1, Alexandra Leopoldi2, Martin Aichinger3,4, Dontscho Kerjaschki5, Josef M Penninger6,7.   

Abstract

Blood vessels are fundamental to animal life and have critical roles in many diseases, such as stroke, myocardial infarction and diabetes. The vasculature is formed by endothelial cells that line the vessel and are covered with mural cells, specifically pericytes in smaller vessels and vascular smooth muscle cells (vSMCs) in larger-diameter vessels. Both endothelial cells and mural cells are essential for proper blood vessel function and can be derived from human pluripotent stem cells (hPSCs). Here, we describe a protocol to generate self-organizing 3D human blood vessel organoids from hPSCs that exhibit morphological, functional and molecular features of human microvasculature. These organoids are differentiated via mesoderm induction of hPSC aggregates and subsequent differentiation into endothelial networks and pericytes in a 3D collagen I-Matrigel matrix. Blood vessels form within 2-3 weeks and can be further grown in scalable suspension culture. Importantly, in vitro-differentiated human blood vessel organoids transplanted into immunocompromised mice gain access to the mouse circulation and specify into functional arteries, arterioles and veins.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31554955     DOI: 10.1038/s41596-019-0213-z

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  35 in total

Review 1.  Angiogenic biomaterials to promote therapeutic regeneration and investigate disease progression.

Authors:  Mai T Ngo; Brendan A C Harley
Journal:  Biomaterials       Date:  2020-06-14       Impact factor: 12.479

Review 2.  The Role of ADAM17 in Inflammation-Related Atherosclerosis.

Authors:  Bai-Yi Tang; Jin Ge; Yang Wu; Juan Wen; Xiao-Hong Tang
Journal:  J Cardiovasc Transl Res       Date:  2022-06-01       Impact factor: 4.132

Review 3.  Engineered human blood-brain barrier microfluidic model for vascular permeability analyses.

Authors:  Cynthia Hajal; Giovanni S Offeddu; Yoojin Shin; Shun Zhang; Olga Morozova; Dean Hickman; Charles G Knutson; Roger D Kamm
Journal:  Nat Protoc       Date:  2022-01-07       Impact factor: 13.491

Review 4.  The role of neutrophils in rheumatic disease-associated vascular inflammation.

Authors:  Lihui Wang; Raashid Luqmani; Irina A Udalova
Journal:  Nat Rev Rheumatol       Date:  2022-01-17       Impact factor: 20.543

Review 5.  Defense of COVID-19 by Human Organoids.

Authors:  Ting Lv; Fanlu Meng; Meng Yu; Haihui Huang; Xinhua Lin; Bing Zhao
Journal:  Phenomics       Date:  2021-07-14

Review 6.  Updated perspectives on vascular cell specification and pluripotent stem cell-derived vascular organoids for studying vasculopathies.

Authors:  Chenxin Liu; Kaiyuan Niu; Qingzhong Xiao
Journal:  Cardiovasc Res       Date:  2022-01-07       Impact factor: 10.787

Review 7.  Organ-on-a-chip systems for vascular biology.

Authors:  Christian J Mandrycky; Caitlin C Howard; Samuel G Rayner; Yu Jung Shin; Ying Zheng
Journal:  J Mol Cell Cardiol       Date:  2021-06-09       Impact factor: 5.763

Review 8.  Integration of Transformative Platforms for the Discovery of Causative Genes in Cardiovascular Diseases.

Authors:  Haocheng Lu; Jifeng Zhang; Y Eugene Chen; Minerva T Garcia-Barrio
Journal:  Cardiovasc Drugs Ther       Date:  2021-04-15       Impact factor: 3.947

Review 9.  Patient-Derived Cancer Organoids for Precision Oncology Treatment.

Authors:  Mark N Pernik; Cylaina E Bird; Jeffrey I Traylor; Diana D Shi; Timothy E Richardson; Samuel K McBrayer; Kalil G Abdullah
Journal:  J Pers Med       Date:  2021-05-17

Review 10.  The potential roles of Von Willebrand factor and neutrophil extracellular traps in the natural history of hypertrophic and hypertensive cardiomyopathy.

Authors:  Richard C Becker; A Phillip Owens; Sakthivel Sadayappan
Journal:  Thromb Res       Date:  2020-05-07       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.